Organon Pharma (UK) Limited is a global healthcare company focused on advancing women’s health through innovative pharmaceutical solutions. Established in 1964, Organon has a long history of research, development, and commercialization of medicines addressing a range of therapeutic areas. The company operates primarily within the UK, with a significant international presence spanning Europe, North America, and Asia. Organon specializes in the discovery, development, and marketing of prescription medicines, focusing on areas including fertility, menopause, and women’s health. Their core business model centers on providing targeted therapies to improve patient outcomes and quality of life. The company’s strategic focus is on developing and delivering solutions that address unmet medical needs within these key areas. Organon’s operations encompass a diverse portfolio of products, including hormone therapies, fertility treatments, and menopause management medications. They are dedicated to leveraging scientific advancements and strategic partnerships to bring novel therapies to market. The company employs a global workforce and maintains a strong commitment to ethical business practices and patient safety. Organon Pharma is classified as a limited company (Ltd) under the SIC codes - 21100: Manufacture of basic pharmaceutical products. The company is currently rated as a Worker (A rating) for Visa purposes.

Organon Pharma (UK) Limited is a global healthcare company focused on advancing women’s health through innovative pharmaceutical solutions. Established in 1964, Organon has a long history of research, development, and commercialization of medicines addressing a range of therapeutic areas. The company operates primarily within the UK, with a significant international presence spanning Europe, North America, and Asia. Organon specializes in the discovery, development, and marketing of prescription medicines, focusing on areas including fertility, menopause, and women’s health. Their core business model centers on providing targeted therapies to improve patient outcomes and quality of life. The company’s strategic focus is on developing and delivering solutions that address unmet medical needs within these key areas. Organon’s operations encompass a diverse portfolio of products, including hormone therapies, fertility treatments, and menopause management medications. They are dedicated to leveraging scientific advancements and strategic partnerships to bring novel therapies to market. The company employs a global workforce and maintains a strong commitment to ethical business practices and patient safety. Organon Pharma is classified as a limited company (Ltd) under the SIC codes - 21100: Manufacture of basic pharmaceutical products. The company is currently rated as a Worker (A rating) for Visa purposes.